NEW YORK (GenomeWeb) – Cenix BioScience this week announced it has signed an agreement to provide target-validation services to BASF company Metanomics.
Specifically, Cenix will characterize the function of Metanomics-specified gene targets in an undisclosed indication using its high-content screening and image-analysis technologies.
Financial terms of the deal were not disclosed.